Radiesse Injection Depth | Technique, Safety Guide

Radiesse must be precisely injected into the deep subcutaneous or supraperiosteal layer, and is often diluted 1:1 to stimulate collagen regeneration. Clinical practice has confirmed that results last 12-18 months. Operations must be performed by professional physicians, avoiding blood vessels to ensure medical safety and achieve a natural contour lift.

Technique

A single 1.5ml of Radiesse contains 30% CaHA microspheres (25-45μm) and 70% CMC gel. In clinical practice, 22G-25G blunt are commonly used for operation. Deep contouring uses 0.1ml/point bolus injection; superficial improvement of skin texture requires 1:1 to 1:6 dilution. It relies on a high G’ value (elastic modulus) to provide physical support. 3 months after injection, Type I collagen regeneration is induced through fibroblast mechanical stress, with effects usually lasting 12 to 18 months.

Tool Specification Selection

Radiesse undiluted solution has extremely high viscoelasticity and a G’ value (elastic modulus can reach approximately 1400 Pa), which places strict requirements on the internal diameter of injection tools. The 1.5ml pre-filled uses a Luer-lock safety interface to withstand the significant pressure generated during injection. In the initial stage of tool selection, 22G and 25G blunt are the most common specifications in international clinical applications. A 22G blunt has an outer diameter of approximately 0.72mm and an inner diameter of approximately 0.48mm. The larger internal space effectively reduces injection resistance, ensuring that CaHA microspheres flow evenly within the CMC gel carrier and avoiding physical accumulation at the tip. In contrast, 25G blunt (outer diameter 0.51mm, inner diameter approximately 0.30mm) generate higher extrusion force during operation, usually requiring the operator to apply a force of 15 to 25 Newtons (N). If the selected ‘s inner diameter is less than 0.2mm, CaHA microspheres may aggregate when passing through the narrow space, leading to blockage or uneven dosage. Commonly used blunt lengths are 38mm, 50mm, and 70mm. A 50mm blunt can cover most of the treatment area from a single entry point when operating on the cheeks, reducing the number of skin puncture points and thereby lowering the probability of postoperative bruising. Data shows that using a single entry point combined with a 50mm blunt reduces local tissue damage area by approximately 40% compared to multiple puncture methods. For large-area coverage of the back of the hand, a 70mm blunt shows better flexibility, allowing for a one-time crossing of the metacarpal area to achieve a fan-shaped distribution of material in the superficial subcutaneous layer.

High-quality medical stainless steel often feature a thin-wall design, which increases the internal diameter without changing the outer diameter, crucial for maintaining the integrity of Radiesse particles. When performing Hyperdilute (high-ratio mixing) operations, the scope of tools extends to connectors and auxiliary. In clinical practice, a three-way stopcock or a female-to-female adapter is usually used to connect the 1.5ml Radiesse with a 3.0ml or 5.0ml empty. After more than 20 reciprocating mixing strokes, the physical properties of the material transform from a high-viscosity gel state to a more fluid state. Material in this state can be operated through finer 27G or even 30G for improving skin texture on the neck or body parts. Clinical surveys show that when extrusion force exceeds 30N, the operator’s hand stability decreases by approximately 15%, which may lead to slight deviations in injection depth. Therefore, when handling undiluted solution without significant mixing, a 22G blunt is the preferred choice for maintaining precision. In hand rejuvenation, where the skin on the back of the hand is thin and blood vessels are densely distributed, using a 25G blunt combined with lidocaine mixture can provide a smoother coverage effect while ensuring safety.

Connectors must comply with the 9-7 standard to ensure no interface detachment or material leakage occurs during high-pressure mixing. When mixing at a 1:1 ratio, a 3.0ml is recommended as the mating as it provides the best pressure feedback. If the dilution ratio reaches 1:4 or higher, a 10ml should be used to accommodate more saline. This change in volume ratio not only affects the diffusion speed of the material in the tissue but also alters the distribution density of CaHA microspheres per unit area. Research shows that diluted material is distributed more evenly under the skin, and its biostimulatory range is approximately 2.5 times larger than that of undiluted bolus injection. In sharp scenarios, 27G 13mm are often used for micro-bolus injection on the deep periosteum. This method utilizes the extreme lifting capacity of Radiesse to produce immediate contour lifting effects through small-dose physical stacking. Since sharp carry the risk of penetrating blood vessel walls, operations must strictly follow aspiration protocols, observing for no less than 5-10 seconds. If using a 27G for original solution injection, operators must be careful not to use excessive force due to high resistance, preventing the from bursting at the interface due to excessive pressure.

Injection Layer Differentiation

In the deepest Supraperiosteal Layer, injection depth generally varies between 5mm and 10mm depending on the facial region. In this layer, the material primarily functions for physical displacement and structural support. Since the G’ (elastic modulus) of CaHA is around 1400 Pa, significantly higher than most monophasic or biphasic hyaluronic acids, it can simulate the hardness of bony structures, providing stable lifting force for the mandibular angle, chin, or zygomatic area. During operation, the tip should enter vertically and contact the bone plate. After aspiration confirms no blood, a small bolus of 0.1ml to 0.3ml is injected. Because this layer lacks a rich capillary network, the degradation speed of the material is relatively slow, providing stable support for facial contours for over a year. At this depth, even if the material is slightly unevenly distributed, no visible protrusions will be observed on the skin surface.

After entering the Deep Subcutaneous Layer, the operation logic shifts from “support” to “volume coverage.” This layer is usually located above the SMAS fascia layer, at a depth of about 3mm to 5mm. At this point, the CMC gel carrier (70% of total volume) provides immediate filling. Through 22G or 25G blunt, using linear retrograde injection techniques, the material can be evenly placed between fat pads. Injection at this depth can avoid physical compression of the material by frequent facial muscle movements, preventing material displacement. In this layer, CaHA microspheres begin to contact surrounding fat cells and connective tissue, triggering a preliminary biostimulatory response. Note that when treating this layer, the volume of a single injection should not be excessive, usually controlled within 0.1ml per linear injection path, to ensure good integration with host tissue and avoid palpable nodules. In the shallower Subdermal Layer, operation difficulty increases significantly because this layer is close to the dermal tissue, with a depth of only 1mm to 2mm. If undiluted solution is injected at this level, the high viscoelasticity of CaHA can easily lead to skin blanching, nodules, or irregular protrusions. Therefore, at this depth, Hyperdilute technology must be used. Mixing 1.5ml of Radiesse with saline at ratios of 1:1, 1:3, or even 1:6 transforms it into a low-viscosity fluid. In this layer, CaHA microspheres no longer act as fillers but as mechanical signal transduction inducers. Fibroblasts, upon contact with these 25-45μm microspheres, are stimulated by mechanical stress, thereby initiating the synthesis of Type I collagen and elastic fibers. Clinical data shows that 3 months after 1:1 dilution and subdermal injection, local tissue collagen density is significantly higher than pre-treatment. Injection at this level is the primary means of improving skin laxity and fine lines.

• Mechanical Stress Activation: At 1mm-2mm depth, the physical contact area between microspheres and fibroblasts is maximized, effectively inducing the phenotypic transformation of contractile fibroblasts.
• Vector Lifting Effect: Radial or fan-shaped spreading in the middle subcutaneous layer can utilize the material’s cohesivity to produce tissue contraction force perpendicular to gravity.
• Diluent Diffusion Path: At high dilution ratios, the liquid spreads rapidly through connective tissue septa, allowing CaHA microspheres to distribute in a single or thin layer, avoiding clump-like accumulation.
• Vascular Anatomy Avoidance: In facial danger zones (such as the temple or paranasal area), strictly limiting injection to the supraperiosteal layer can significantly reduce the probability of accidental entry into the facial artery or superficial temporal artery branches.

For body parts like hands or neck, layer selection is even more rigorous. Hand injections must remain in the loose connective tissue layer between the superficial fascia and extensor tendons, usually less than 1.5mm deep. By using high dilution ratios (such as 1:2 or 1:3) combined with blunt spreading, exposed veins and bone shapes on the back of the hand can be masked. Neck injection depth should be controlled in the subdermal layer (about 0.5mm-1.0mm), using micro-quantity grid spreading to induce biological tightening effects in neck skin. In these areas, a deviation in depth of even 0.5mm could change the result from “smooth” to “grainy.”

Dilution Ratio

Before adding any liquid, Radiesse has an elastic modulus (G’) of about 1400 Pa and a viscosity above 300,000 cP, giving it extreme in-situ stability within tissue. To expand the application range of this material, international clinical consensus introduced the concept of Hyperdilute. This operation adjusts the rheological properties of the material by adding different volumes of 0.9% saline or 1% lidocaine to the 1.5ml original solution. When adding 1.5ml of liquid to form a 1:1 ratio, the mixture’s G’ value drops to approximately 500-600 Pa. At this point, the material’s diffusion capability is enhanced, while it still retains some volume-filling capacity. If the liquid volume is increased to 3.0ml (1:2 ratio) or more, the physical displacement effect of the material basically disappears, and it relies entirely on the mechanical stretching force generated by CaHA microspheres on fibroblasts to induce biological responses. Research data indicates that the distribution density of CaHA microspheres in tissue is inversely proportional to the amount of liquid added. By accurately calculating the number of microspheres allocated per square centimeter of skin, a precise transition from deep volume support to superficial dermal thickening can be achieved.

According to data from the International Society for Dermatologic Surgery, CaHA microspheres in Hyperdilute mode are distributed diffusely in the subdermal layer, inducing approximately 25%-30% more Type I collagen production than high-concentration bolus mode, with fibroblast activity peaking at 4 weeks post-operation.

A 1:1 ratio is the benchmark formula for facial rejuvenation, usually mixing 1.5ml of original solution with 1.5ml of lidocaine solution. The mixture at this ratio has good extrusion compliance and can easily pass through a 25G blunt. For the cheek area where skin thickness is between 1.5mm and 2.0mm, a 1:1 mixture distributes evenly in the subcutaneous fat layer, reducing the risk of nodules caused by high material cohesivity. In body parts, such as treating skin laxity on the inner upper arm or above the knees, the ratio usually needs to be increased to 1:3. At this point, every 1.5ml of original solution needs to be mixed with 4.5ml of saline, reaching a total volume of 6.0ml. For physical mixing techniques, a Luer-lock three-way stopcock or female-to-female connector must be used. The operator connects the 1.5ml containing the original solution with a 10ml containing the diluent, performing at least 20 to 50 reciprocating strokes. The shear force generated at the connection port ensures homogenous distribution of CaHA microspheres in the CMC gel and saline. If the number of mixing strokes is insufficient, microspheres can easily layer in the liquid, causing a large amount of water to be ejected initially followed by high-concentration microsphere accumulation. Such uneven distribution increases the risk of local inflammatory reactions. The mixed liquid should appear as a uniform milky white and should not produce visible sediment within 10 minutes of standing. If the operation takes a long time, it is recommended to perform 2-3 additional mixing strokes before injecting each 1ml to maintain physical consistency.

Histological studies confirmed that CaHA mixed at a 1:2 ratio increased elastic fiber density in the dermis by about 20% after 6 months, which is quantitatively significant for improving fine wrinkles and skin elasticity.

For specific areas like the neck, where skin layers are extremely thin and vascular distribution is superficial, a ratio of 1:2 to 1:4 is typically used. Under such high dilution ratios, the concentration of CaHA microspheres is significantly thinned, reducing the amount of active microspheres per milliliter, which lowers the physical basis for nodule formation in these areas. Clinical follow-up data shows that patients treated for neck horizontal lines with a 1:2 ratio had 45% higher satisfaction than those treated with undiluted injection, mainly manifested as improved skin texture smoothness and naturalness. At the same time, the increased proportion of lidocaine in the mixture significantly reduces the patient’s pain during fan-shaped spreading, with the Visual Analogue Scale (VAS) score typically dropping from 6 for original injection to below 2.

When performing high-ratio mixing, the choice of added liquid needs to be adjusted according to the purpose. If immediate pain relief is sought, 1% or 2% lidocaine is the first choice; If there is a concern about lidocaine toxicity in large-area body contouring (due to large total volume), 0.9% saline should be the main additive medium, with only a small proportion of local anesthetic added. This volume expansion technique allows the coverage area of a single Radiesse to extend from a few points on the face to large areas of the entire face or even the whole body. Regarding injection pressure feedback, as the dilution ratio increases, the extrusion resistance felt by the operator decreases linearly, allowing the use of finer 27G for extremely precise superficial texture modification. Physical residual data at different ratios indicates that although high-ratio mixing reduces material concentration at a single point, the penetration depth of CaHA microspheres into tissue gaps actually increases by about 15%-20% due to the increased total liquid volume. This penetration effect allows the biostimulatory action to reach deeper fibroblast populations. In long-term postoperative observation, skin tightening effects in the high-ratio mixture group usually begin to appear in the 3rd month and reach a stable phase by the 6th to 9th month.

Safety Guide

The physical composition of Radiesse includes 30% Calcium Hydroxylapatite (CaHA) and 70% gel. Its elastic modulus (G’) is approximately 1400 Pa, with particle diameters between 25 and 45 micrometers. Clinical data indicates that aspiration should be performed for 5 to 10 seconds during operation. Controlling the single-point injection volume to below 0.1ml can significantly reduce irregularities. Using 22G or 25G blunt can avoid major facial blood vessels. Through liquid mixing ratios of 1:1 to 1:4, Type I collagen production can be promoted, with effects usually lasting 12 to 18 months.

Preoperative Screening Criteria

Radiesse consists of 30% Calcium Hydroxylapatite (CaHA) microspheres and 70% Carboxymethyl Cellulose (CMC) gel. The elastic modulus (G’) of this filler reaches 1400 Pa, making it one of the materials with high physical strength on the market. Before starting any operation, it must be verified whether the patient falls within the or scope of application. It is generally recommended that patients be between 25 and 65 years old, as the fibroblast activity of this group is sufficient to respond to CaHA microspheres and secrete Type I collagen. For people over 70 years old or long-term smokers, skin thickness is usually less than 0.5 mm. The probability of visible subcutaneous nodules in this group after injection is 15% to 20% higher than in the general population due to a thin dermal layer. Assessment requires checking if there is an active infection in the injection area within 2 weeks, including herpes simplex, acne vulgaris, or cellulitis. CaHA particle diameters are distributed between 25-45 micrometers. While this size avoids immediate phagocytosis by macrophages, chronic inflammation in the tissue can induce the aggregation of foreign body macrophages, leading to the formation of non-inflammatory granulomas.

Medical history collection must cover immune system diseases, such as systemic lupus erythematosus, rheumatoid arthritis, or Hashimoto’s thyroiditis. Clinical observations have found that patients with active immune diseases will experience a local edema period prolonged from the normal 3-5 days to more than 14 days after receiving CaHA injection. For patients undergoing immunosuppressive therapy or taking prednisone long-term (dose exceeding 5mg/day), the biostimulatory effect of collagen regeneration will significantly decrease, leading to lower-than-expected treatment satisfaction. Furthermore, operators need to assess dental history; if tooth extraction, root canal therapy, or periodontal surgery is planned within 2 weeks, Radiesse injection should be postponed. Streptococci in the oral cavity may migrate to the vicinity of facial fillers through blood circulation, forming a biofilm. Once a biofilm is formed, antibiotic penetration will drop to 1/1000 of normal levels. For women planning pregnancy or breastfeeding, although CaHA itself is a mineral component present in human bones, there is currently a lack of Phase IV clinical trial data to prove its safety for embryos or infants, thus it should be listed as a contraindication according to international standards. In facial anatomical assessment, subcutaneous tissue thickness at the target site needs to be measured. If the target area is the neck or hand and the skin thickness is below 1 mm, a dilution ratio of 1:1 to 1:4 must be used. Injecting undiluted solution directly under very thin skin will lead to uneven particle distribution, forming visible white cord-like protrusions. Before operation, it is also necessary to verify if the patient has received high-energy device treatments such as High-Intensity Focused Ultrasound (HIFU) or monophasic radiofrequency within the past 6 months. It is recommended to wait until tissue inflammation has completely subsided before performing CaHA injection to prevent synergistic reactions between thermal effects and microspheres leading to excessive tissue fibrosis.

The effects of Radiesse are divided into two stages: the first 1 to 3 months are provided by physical support from CMC gel; as the gel is absorbed, the effect is maintained by new collagen fibers after 3 months. If a patient expects to be able to dissolve the filler at any time like hyaluronic acid with hyaluronidase, they are not suitable for CaHA, as there is currently no specific degrading enzyme for CaHA. Patients must be informed that once injected, the material will remain in the body for 12 to 18 months until completely metabolized. This long-term nature requires precise marking of injection sites before surgery, avoiding the infraorbital foramen (located about 5-10 mm below the infraorbital rim) and the mental foramen. For patients with frequent international travel plans, it is recommended to complete the operation at least 14 days before departure to allow sufficient observation time to handle any potential delayed allergies or slight displacements.

Abnormal Reaction Handling

Initial reactions after Radiesse injection mainly focus on the tissue displacement effect produced by Carboxymethyl Cellulose (CMC) gel. Since the G’ value of this material is as high as 1400 Pa, there will be a noticeable sense of hardness and slight swelling in the local tissue within 24 to 72 hours after injection, which is a normal physiological feedback of physical filling. Clinical data shows that about 25% of patients will experience various degrees of bruising, especially when operating with sharp in vascularly rich subcutaneous areas. To quantify risk, if a single injection volume exceeds 0.1 ml, local tissue internal pressure will rise rapidly, potentially compressing capillaries and leading to local ischemia. At this point, fullness should be checked by palpation to ensure material has not accumulated in the deep dermis. For redness and swelling, cold compresses for 15 minutes every 2 hours are recommended within 24 hours post-operation, which can effectively reduce the release rate of inflammatory factors like prostaglandins and shorten the recovery period to 3 to 5 days.

Vascular occlusion is the highest-risk scenario in filling operations. Because CaHA microsphere diameters are 25-45 micrometers and lack enzyme-degrading properties like hyaluronic acid, once they enter a vessel, the blockage is physically irreversible. When the tip accidentally enters a facial artery (such as the facial artery or supratrochlear artery), the patient will experience intense radiating pain, followed by typical Livedo Reticularis on the skin. In this case, all operations must stop within 60 seconds. While there is no specific dissolving enzyme, clinical practice usually involves local irrigation with large amounts of saline to dilute microsphere density. Meanwhile, oral intake of 325 mg of aspirin is suggested to prevent further platelet aggregation at the site of embolism. If local tissue turns dark or pale, 2% nitroglycerin ointment can be applied locally every 2 hours to improve collateral circulation by dilating blood vessels. Emergency intervention process for vascular accidents:

• Physical Compression & Massage: Use strong manual massage to attempt to push microspheres at the site of embolism toward finer distal branches or disperse them into surrounding gaps.
• Hot Compress for Circulation Induction: Perform hot compresses for 15 minutes every hour, maintaining local temperature at 38-40 degrees Celsius to enhance local metabolism.
• Medication Support Regimen: For ischemic areas, subcutaneous injection of low-molecular-weight heparin or intravenous drip of vasodilators can be considered, with an observation period of no less than 48 hours.
• Hyperbaric Oxygen Therapy Assessment: If skin blisters or epidermal sloughing occurs, hyperbaric oxygen therapy should be started as soon as possible to increase tissue oxygen content and prevent full-thickness necrosis.

When CaHA is injected in undiluted form into the dermis rather than subcutaneous tissue, fibroblasts will produce an excessive fibrotic reaction, wrapping the microspheres to form nodules. Non-inflammatory nodules usually appear 4 to 8 weeks post-operation, feeling hard but without redness or swelling. Studies have found that adjusting the ratio to 1:1 to 1:4 dilution (Hyperdilute) allows microspheres to be more evenly scattered within Type I and Type III collagen scaffolds, reducing the incidence of nodules from 3.5% to below 0.5%. When treating formed nodules, local infiltration dissection with saline combined with lidocaine can be used to redistribute aggregated microspheres through physical pressure. For persistent granulomas, local point injection with a mixture of 5-Fluorouracil (5-FU) and triamcinolone is recommended. 5-FU can inhibit excessive fibroblast proliferation. Treatments are usually every 3-4 weeks; after 2 to 3 sessions, nodule volume can be reduced by more than 60% on average.

After injection, the CMC gel carrier of CaHA microspheres is completely absorbed by the body within 12 weeks. The remaining microspheres act as a scaffold, continuously inducing collagen regeneration for 6 to 9 months. If the patient experiences local hardening or unevenness during this phase, palpation is needed to determine if it is tissue fibrosis or material residue. In clinical practice, for visible protrusions caused by incorrect anatomical leveling, high-frequency radiofrequency or ultrasound energy can be used for heat treatment if massage is ineffective. Thermal effects can induce partial remodeling of the collagen scaffold, thereby smoothing tissue contours. Patients must be informed that the metabolism of CaHA is a slow calcium-phosphorus replacement process, and typically after 12 to 18 months, microspheres will be phagocytosed by macrophages and excreted via the kidneys.

Postoperative Follow-up Arrangement

The first 24 to 72 hours after Radiesse injection is the initial stabilization period. Since Carboxymethyl Cellulose (CMC) gel accounts for 70% of the total volume, its high elastic modulus of 1400 Pa will generate significant mechanical pressure on local tissue in a short time. During the first follow-up (usually arranged 48 hours post-operation via remote or in-person consultation), skin temperature and color need to be confirmed. Clinical data shows that about 15% to 22% of patients will experience mild erythema due to temporary compression of deep dermal microcirculation by the high G’ material. Patients are advised to avoid any strenuous exercise that results in a heart rate exceeding 120 beats/minute for 3 days post-operation, as increased blood flow will exacerbate initial edema, prolonging the recovery period by more than 30%. Meanwhile, contact with high-temperature environments exceeding 40 degrees Celsius, including saunas, sunbathing, or long hot showers, must be strictly limited to prevent premature unexpected diffusion of the CMC gel due to vasodilation.

Patients need to perform local observation for the first 3 days post-operation, recording any throbbing pain lasting more than 6 hours or pale skin areas exceeding 5 mm in size.

At the Week 2 postoperative follow-up, the focus shifts to assessing the preliminary uniformity of material distribution. By this time, initial edema has subsided by about 90%, and the physical displacement effect of Radiesse is at its clearest. For neck or hand treatment cases using 1:1 or 1:2 dilution (Hyperdilute), palpation is required to check for micro-protrusions formed by particle aggregation. If scattered hard lumps with a diameter smaller than 2 mm are found during follow-up, patients are usually required to perform the “5-5-5” massage method: massage 5 times a day, for 5 minutes each time, for 5 days. This physical intervention ensures that CaHA microspheres are evenly distributed around fibroblasts before the CMC gel degrades. Data shows that standardized 2-week follow-up and timely massage guidance can reduce the incidence of later nodules from 3.1% to around 0.4%.

Postoperative Day 14 is the last window for intervening in the material’s distribution position; at this time, tissue has not yet formed solid fibrous encapsulation, and the planar layout of microspheres can still be adjusted through mechanical massage.

Entering the 3rd Month post-operation, follow-up moves into the assessment stage of biological effect transformation. This is the most unique period for Radiesse, as 70% of the CMC gel has basically been absorbed, while 25-45 micrometer CaHA microspheres start acting as a scaffold, inducing the regeneration of Type I collagen and elastic fibers. Clinical observations show that patients might feel a slight decrease in fullness during this stage, known as the “volume trough period.” Follow-up should utilize 3D imaging systems (such as Canfield Vectra) to measure skin surface roughness and dermal thickness. Studies confirm that during this stage, collagen density within the dermis increases by an average of 15% to 25%.

In the Day 90 postoperative follow-up, the focus of assessment should shift from “volume filling” to “skin texture improvement,” observing the enhancement of skin elastic recoil and radiance.

The 6-month medium-to-long-term follow-up is the standard for determining treatment success. By now, new collagen has formed a stable Extracellular Matrix (ECM), and CaHA microspheres are surrounded by a large amount of connective tissue. Follow-up should focus on whether Delayed Inflammatory Reaction (LIR) exists; although its incidence is below 1% in international clinical records, it is still necessary to check for local redness or tenderness without known cause. For patients over 55 years old, since their own fibroblast synthesis capacity is weaker, it may be necessary to discuss a second micro-reinforcement during this follow-up. Statistical suggestions show that adding 20% to 30% of the original dose 6 to 9 months after the first injection can extend the overall maintenance period from the normal 12 months to more than 18 months.

Long-term follow-up should be conducted every 6 months, recording changes in tissue texture during the metabolism of CaHA microspheres to ensure no late-onset non-inflammatory granulomas have occurred.